Akinari Tsukada
Overview
Explore the profile of Akinari Tsukada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsukada A, Katagiri D, Izumi S, Terada-Hirashima J, Shimizu Y, Uemura Y, et al.
Cureus
. 2025 Mar;
17(2):e78836.
PMID: 40084335
Introduction Direct hemoperfusion using polymyxin B-immobilized polystyrene fiber column (PMX-DHP) removes endotoxin and inflammatory mediators from the blood. This study aimed to evaluate the changes in the levels of cytokines,...
2.
Okumura N, Kutsuna S, Tsukada A, Mezaki K, Nagashima M, Ohmagari N
IJID Reg
. 2024 Oct;
13:100443.
PMID: 39386113
There is a paucity of data on the clinical course and treatment of . Herein, we describe a successfully treated case of bacteremia. A 76-year-old man with lung adenocarcinoma developed...
3.
Tsukada A, Morita C, Shimizu Y, Uemura Y, Naka G, Takasaki J, et al.
Thorac Cancer
. 2024 Aug;
15(25):1854-1862.
PMID: 39086088
Background: Recent advancements in advanced non-small-cell lung cancer (NSCLC) treatment have significantly improved primary therapy outcomes owing to the emergence of various molecular targeted therapies and immune checkpoint inhibitors (ICIs)....
4.
Katagiri D, Tsukada A, Izumi S, Shimizu Y, Terada-Hirashima J, Uemura Y, et al.
Sci Rep
. 2024 May;
14(1):12550.
PMID: 38822071
Extracorporeal blood purification with polymyxin B immobilized fiber column direct hemoperfusion (PMX-DHP), is reported to be effective in treating COVID-19 pneumonitis with oxygen demand. This multicenter prospective study evaluated the...
5.
Katsuno T, Kimura M, Terada-Hirashima J, Kazuyama Y, Ikeda M, Moriya A, et al.
J Virol Methods
. 2024 Mar;
326:114909.
PMID: 38452822
This study aimed to evaluate diagnostic accuracy of SARS-CoV-2 RNA detection in saliva samples treated with a guanidine-based or guanidine-free inactivator, using nasopharyngeal swab samples (NPS) as referents. Based on...
6.
Tsukada A, Terada-Hirashima J, Takasaki J, Nokihara H, Izumi S, Hojo M, et al.
BMC Pulm Med
. 2024 Mar;
24(1):105.
PMID: 38431557
Background: While the prevalence of severe cases and mortality rate of coronavirus disease 2019 (COVID-19) appear to be reducing, the clinical characteristics and severity of hospitalized patients with asthma and...
7.
Hatano H, Tsujimoto Y, Watanabe H, Tsukada A, Izumi S, Nagasaka S, et al.
Respir Investig
. 2023 Apr;
61(4):405-408.
PMID: 37099891
A 41-year-old man presented with chronic cough and chest pain. Laboratory tests revealed anemia, inflammation, hypoalbuminemia, polyclonal hypergammaglobulinemia, and elevated interleukin-6 levels. Computed tomography revealed diffuse bilateral pulmonary nodules and...
8.
Katsuno T, Suzuki M, Morishita M, Kawajiri K, Saito S, Horikawa Y, et al.
Glob Health Med
. 2023 Mar;
5(1):47-53.
PMID: 36865899
High-flow nasal cannula (HFNC) can be effective in treating type 1 respiratory failure by reducing the severity of coronavirus disease 2019 (COVID-19). The purpose of this study was to assess...
9.
Tamura A, Suzuki M, Tsukada A, Hojo M
Intern Med
. 2022 Nov;
62(12):1867-1868.
PMID: 36351582
No abstract available.
10.
Kusaba Y, Takeda Y, Abe S, Tsukada A, Naka G
Medicine (Baltimore)
. 2022 Aug;
101(32):e29682.
PMID: 35960133
Rationale: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are widely used for the treatment of EGFR mutation positive advanced nonsmall cell lung cancer (NSCLC); however, acquired resistance is...